Toward beta cell replacement for diabetes

EMBO Journal

Volumn 34, Issue 7, 2015, Pages 841-855

  Johannesson, Bjarki ^a   Sui, Lina ^b   Freytes, Donald O ^a   Creusot, Remi J ^c   Egli, Dieter ^a,b  

^a New York Stem Cell Foundation   (United States)

^b Columbia University ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

beta cells; cell replacement therapy; stem cells; type 1 diabetes

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BIOENGINEERING; CELL DIFFERENTIATION; CELL ENCAPSULATION; HUMAN; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MONOTHERAPY; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VASCULARIZATION; ANIMAL; AUTOGRAFT; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; NUCLEAR REPROGRAMMING; PATHOLOGY; TRANSPLANTATION;

ANIMALS; AUTOGRAFTS; CELLULAR REPROGRAMMING; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSION; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84926246629     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201490685     Document Type: Review

References (140)

1. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M, (2001) Insulin production by human embryonic stem cells. Diabetes 50: 1691-1697
2. Badylak SF, Freytes DO, Gilbert TW, (2009) Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 5: 1-13
3. Badylak SF, Taylor D, Uygun K, (2011) Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 13: 27-53
4. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S, (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 108: 14234-14239
5. Barcala Tabarrozzi AE, Castro CN, Dewey RA, Sogayar MC, Labriola L, Perone MJ, (2013) Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. Clin Exp Immunol 171: 135-146
6. Bar-Nur O, Russ HA, Efrat S, Benvenisty N, (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9: 17-23
7. Barthson J, Germano CM, Moore F, Maida A, Drucker DJ, Marchetti P, Gysemans C, Mathieu C, Nuñez G, Jurisicova A, Eizirik DL, Gurzov EN, (2011) Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 286: 39632-39643
8. Basel MT, Balivada S, Beck AP, Kerrigan MA, Pyle MM, Dekkers JC, Wyatt CR, Rowland RR, Anderson DE, Bossmann SH, Troyer DL, (2012) Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: a human tumor model in pigs. BioRes Open Access 1: 63-68
9. Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA, (2012) Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes 61: 1519-1526
10. Bilbao D, Luciani L, Johannesson B, Piszczek A, Rosenthal N, (2014) Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease. EMBO Mol Med 6: 1423-1435
11. Bouchi R, Foo KS, Hua H, Tsuchiya K, Ohmura Y, Sandoval PR, Ratner LE, Egli D, Leibel RL, Accili D, (2014) FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures. Nat Commun 5: 4242
12. Brehm MA, Powers AC, Shultz LD, Greiner DL, (2012) Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harb Perspect Med 2: a007757
13. Brizzi MF, Tarone G, Defilippi P, (2012) Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol 24: 645-651
14. Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ, (2014) Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes 7: 211-223
15. Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA, (2010) Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. PLoS ONE 5: e11726
16. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC, (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50: 2323-2331
17. Chatenoud L, (2014) Immunology. Teaching the immune system "self" respect and tolerance. Science 344: 1343-1344
18. Chen YJ, Finkbeiner SR, Weinblatt D, Emmett MJ, Tameire F, Yousefi M, Yang C, Maehr R, Zhou Q, Shemer R, Dor Y, Li C, Spence JR, Stanger BZ, (2014) De novo formation of insulin-producing "neo-beta cell islets" from intestinal crypts. Cell Rep 6: 1046-1058
19. Cheng JYC, Raghunath M, Whitelock J, Poole-Warren L, (2011) Matrix components and scaffolds for sustained islet function. Tissue Eng Part B Rev 17: 235-247
20. Cho YM, Lim JM, Yoo DH, Kim JH, Chung SS, Park SG, Kim TH, Oh SK, Choi YM, Moon SY, Park KS, Lee HK, (2008) Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 366: 129-134
21. Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, Lee Y, Treff NR, Choi YH, Kimbrel EA, Dittman RE, Lanza R, Lee DR, (2014) Human somatic cell nuclear transfer using adult cells. Cell Stem Cell 14: 777-780
22. Coppieters KT, Harrison LC, von Herrath MG, (2013) Trials in type 1 diabetes: antigen-specific therapies. Clin Immunol 149: 345-355
23. Creusot RJ, Giannoukakis N, Trucco M, Clare-Salzler MJ, Fathman CG, (2014) It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes 63: 20-30
24. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE, (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23: 1534-1541
25. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE, (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24: 1392-1401
26. Daoud JT, Petropavlovskaia MS, Patapas JM, Degrandpré CE, Diraddo RW, Rosenberg L, Tabrizian M, (2011) Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials 32: 1536-1542
27. DCCT-Research-Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986
28. Di Lorenzo TP, Peakman M, Roep BO, (2007) Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148: 1-16
29. Fischbach MA, Bluestone JA, Lim WA, (2013) Cell-based therapeutics: the next pillar of medicine. Sci Transl Med 5: 179ps177
30. Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, Oka Y, Urano F, (2005) WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. J Biol Chem 280: 39609-39615
31. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N, (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9: 2717-2726
32. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M, (2011) Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 34: 2026-2032
33. Gittes GK, (2009) Developmental biology of the pancreas: a comprehensive review. Dev Biol 326: 4-35
34. Goh SK, Bertera S, Olsen P, Candiello JE, Halfter W, Uechi G, Balasubramani M, Johnson SA, Sicari BM, Kollar E, Badylak SF, Banerjee I, (2013) Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering. Biomaterials 34: 6760-6772
35. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, et al, (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67
36. Greggio C, De Franceschi F, Figueiredo-Larsen M, Gobaa S, Ranga A, Semb H, Lutolf M, Grapin-Botton A, (2013) Artificial three-dimensional niches deconstruct pancreas development in vitro. Development 140: 4452-4462
37. Greiner DL, Brehm MA, Hosur V, Harlan DM, Powers AC, Shultz LD, (2011) Humanized mice for the study of type 1 and type 2 diabetes. Ann N Y Acad Sci 1245: 55-58
38. Gruessner AC, (2011) 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 8: 6-16
39. Haga K, Lemp NA, Logg CR, Nagashima J, Faure-Kumar E, Gomez GG, Kruse CA, Mendez R, Stripecke R, Kasahara N, Cicciarelli JC, (2006) Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: averting cytotoxicity by alloreactive T lymphocytes. Transpl Proc 38: 3184-3188
40. Hartemann A, Bensimon G, Payan CA, Jacqueminet S, Bourron O, Nicolas N, Fonfrede M, Rosenzwajg M, Bernard C, Klatzmann D, (2013) Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 1: 295-305
41. Hayek A, Lopez AD, Beattie GM, (1989) Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In vitro Cell Dev Biol 25: 146-150
42. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA, (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346: 1692-1698
43. Herold KC, Vignali DA, Cooke A, Bluestone JA, (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13: 243-256
44. Hua H, Shang L, Martinez H, Freeby M, Gallagher MP, Ludwig T, Deng L, Greenberg E, Leduc C, Chung WK, Goland R, Leibel RL, Egli D, (2013) iPSC-derived beta cells model diabetes due to glucokinase deficiency. J Clin Invest 123: 3146-3153
45. Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJ, van de Wetering M, Sojoodi M, Li VS, Schuijers J, Gracanin A, Ringnalda F, Begthel H, Hamer K, Mulder J, van Es JH, de Koning E, Vries RG, Heimberg H, Clevers H, (2013) Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J 32: 2708-2721
46. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N, (2002) Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 16: 169-181
47. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, Mueckler M, Marshall H, Donis-Keller H, Crock P, Rogers D, Mikuni M, Kumashiro H, Higashi K, Sobue G, Oka Y, Permutt MA, (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20: 143-148
48. Johannesson B, Sagi I, Gore A, Paull D, Yamada M, Golan-Lev T, Li Z, LeDuc C, Shen Y, Stern S, Xu N, Ma H, Kang E, Mitalipov S, Sauer MV, Zhang K, Benvenisty N, Egli D, (2014) Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell 15: 634-642
49. Johansson KA, Dursun U, Jordan N, Gu G, Beermann F, Gradwohl G, Grapin-Botton A, (2007) Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 12: 457-465
50. Johnsen AK, Templeton DJ, Sy M, Harding CV, (1999) Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol 163: 4224-4231
51. Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, Greenberg E, Spitzer TR, Savage DG, Tahara H, Choi G, Yang YG, Sykes M, (2012) A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med 4: 125ra130
52. Kasagi S, Zhang P, Che L, Abbatiello B, Maruyama T, Nakatsukasa H, Zanvit P, Jin W, Konkel JE, Chen W, (2014) In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci Transl Med 6: 241ra278
53. Kelly OG, Chan MY, Martinson LA, Kadoya K, Ostertag TM, Ross KG, Richardson M, Carpenter MK, D'Amour KA, Kroon E, Moorman M, Baetge EE, Bang AG, (2011) Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol 29: 750-756
54. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352: 2598-2608
55. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ, (2011) Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 29: 1117-1119
56. Kim H, Kim JS, (2014) A guide to genome engineering with programmable nucleases. Nat Rev Genet 15: 321-334
57. Kind A, Colman A, (1999) Therapeutic cloning: needs and prospects. Semin Cell Dev Biol 10: 279-286
58. Klinke DJ II, (2008) Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PLoS ONE 3: e1374
59. Koyanagi-Aoi M, Ohnuki M, Takahashi K, Okita K, Noma H, Sawamura Y, Teramoto I, Narita M, Sato Y, Ichisaka T, Amano N, Watanabe A, Morizane A, Yamada Y, Sato T, Takahashi J, Yamanaka S, (2013) Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci USA 110: 20569-20574
60. Krishnamurthy M, Li J, Fellows GF, Rosenberg L, Goodyer CG, Wang R, (2011) Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/Akt signaling pathways. Endocrinology 152: 424-435
61. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK, Baetge EE, (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26: 443-452
62. Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G, (2004) Development of definitive endoderm from embryonic stem cells in culture. Development 131: 1651-1662
63. Kunisada Y, Tsubooka-Yamazoe N, Shoji M, Hosoya M, (2012) Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res 8: 274-284
64. Lanza RP, Cibelli JB, West MD, (1999a) Human therapeutic cloning. Nat Med 5: 975-977
65. Lanza RP, Jackson R, Sullivan A, Ringeling J, McGrath C, Kuhtreiber W, Chick WL, (1999b) Xenotransplantation of cells using biodegradable microcapsules. Transplantation 67: 1105-1111
66. Lee K, Kwon DN, Ezashi T, Choi YJ, Park C, Ericsson AC, Brown AN, Samuel MS, Park KW, Walters EM, Kim DY, Kim JH, Franklin CL, Murphy CN, Roberts RM, Prather RS, Kim JH, (2014) Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci USA 111: 7260-7265
67. Lembert N, Wesche J, Petersen P, Doser M, Zschocke P, Becker HD, Ammon HP, (2005) Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant 14: 97-108
68. Lewis EC, (2012) Expanding the clinical indications for alpha(1)-antitrypsin therapy. Mol Med 18: 957-970
69. Liu EH, Digon BJ 3rd, Hirshberg B, Chang R, Wood BJ, Neeman Z, Kam A, Wesley RA, Polly SM, Hofmann RM, Rother KI, Harlan DM, (2009) Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia 52: 1369-1380
70. Ljunggren HG, Karre K, (1990) In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11: 237-244
71. Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M, (1993) Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol 94: 9-20
72. Lutterotti A, Yousef S, Sputtek A, Stürner KH, Stellmann JP, Breiden P, Reinhardt S, Schulze C, Bester M, Heesen C, Schippling S, Miller SD, Sospedra M, Martin R, (2013) Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med 5: 188ra175
73. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA, (2009) Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106: 15768-15773
74. Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M, Group I.-J.T.D.C.T.A. (2010) Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin Exp Immunol 160: 176-184
75. Mendelsohn AD, Bernards DA, Lowe RD, Desai TA, (2010) Patterning of mono- and multilayered pancreatic beta-cell clusters. Langmuir 26: 9943-9949
76. Merani S, Shapiro AM, (2006) Current status of pancreatic islet transplantation. Clin Sci 110: 611-625
77. Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L, (2010) Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology 138: 2233-2245, 2245 e2231-2214
78. Mirmalek-Sani SH, Orlando G, McQuilling JP, Pareta R, Mack DL, Salvatori M, Farney AC, Stratta RJ, Atala A, Opara EC, Soker S, (2013) Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials 34: 5488-5495
79. Nagata N, Gu Y, Hori H, Balamurugan AN, Touma M, Kawakami Y, Wang W, Baba TT, Satake A, Nozawa M, Tabata Y, Inoue K, (2001) Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant 10: 447-451
80. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B, Group D.E.R. (2013) Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes 62: 3976-3986
81. Nir T, Melton DA, Dor Y, (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117: 2553-2561
82. Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A, (2011) DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 7: e1002085-e1002085
83. Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, Mathis D, (2006) Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311: 1775-1778
84. Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G, (2011) Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138: 861-871
85. Oberg-Welsh C, (2001) Long-term culture in matrigel enhances the insulin secretion of fetal porcine islet-like cell clusters in vitro. Pancreas 22: 157-163
86. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y, (2012) Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging 4: 60-73
87. Oram RA, Jones AG, Besser RE, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ, (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57: 187-191
88. Orlando G, Gianello P, Salvatori M, Stratta RJ, Soker S, Ricordi C, Dominguez-Bendala J, (2014) Cell replacement strategies aimed at reconstitution of the beta-cell compartment in type 1 diabetes. Diabetes 63: 1433-1444
89. Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA, (2014) Generation of functional human pancreatic beta cells in vitro. Cell 159: 428-439
90. Parent AV, Russ HA, Khan IS, LaFlam TN, Metzger TC, Anderson MS, Hebrok M, (2013) Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell 13: 219-229
91. Perfetti R, Henderson TE, Wang Y, Montrose-Rafizadeh C, Egan JM, (1996) Insulin release and insulin mRNA levels in rat islets of Langerhans cultured on extracellular matrix. Pancreas 13: 47-54
92. Phelps EA, Headen DM, Taylor WR, Thule PM, Garcia AJ, (2013) Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials 34: 4602-4611
93. Prasad S, Xu D, Miller SD, (2012) Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. Rev Diabet Stud 9: 319-327
94. Qi M, Gu Y, Sakata N, Kim D, Shirouzu Y, Yamamoto C, Hiura A, Sumi S, Inoue K, (2004) PVA hydrogel sheet macroencapsulation for the bioartificial pancreas. Biomaterials 25: 5885-5892
95. Qi M, (2014) Transplantation of encapsulated pancreatic islets as a treatment for patients with type 1 diabetes mellitus. Adv Med 2014: 429710
96. Ressing ME, Luteijn RD, Horst D, Wiertz EJ, (2013) Viral interference with antigen presentation: trapping TAP. Mol Immunol 55: 139-142
97. Rezania A, Bruin JE, Riedel MJ, Mojibian M, Asadi A, Xu J, Gauvin R, Narayan K, Karanu F, O'Neil JJ, Ao Z, Warnock GL, Kieffer TJ, (2012) Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61: 2016-2029
98. Rezania A, Bruin JE, Xu J, Narayan K, Fox JK, O'Neil JJ, Kieffer TJ, (2013) Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 31: 2432-2442
99. Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, O'Dwyer S, Quiskamp N, Mojibian M, Albrecht T, Yang YH, Johnson JD, Kieffer TJ, (2014) Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol 32: 1121-1133
100. Robinton DA, Daley GQ, (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481: 295-305
101. Rodriguez Rilo HL, Ahmad SA, D'Alessio D, Iwanaga Y, Kim J, Choe KA, Moulton JS, Martin J, Pennington LJ, Soldano DA, Biliter J, Martin SP, Ulrich CD, Somogyi L, Welge J, Matthews JB, Lowy AM, (2003) Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg 7: 978-989
102. Roep BO, Kleijwegt FS, van Halteren AG, Bonato V, Boggi U, Vendrame F, Marchetti P, Dotta F, (2010) Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 159: 338-343
103. Sakata N, Sumi S, Yoshimatsu G, Goto M, Egawa S, Unno M, (2012) Encapsulated islets transplantation: past, present and future. World J Gastrointest Pathophysiol 3: 19-26
104. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F, Schwitzgebel V, Hayes-Jordan A, German M, (2000) Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127: 5533-5540
105. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE, (1994) Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43: 1167-1170
106. Schulz TC, Young HY, Agulnick AD, Babin MJ, Baetge EE, Bang AG, Bhoumik A, Cepa I, Cesario RM, Haakmeester C, Kadoya K, Kelly JR, Kerr J, Martinson LA, McLean AB, Moorman MA, Payne JK, Richardson M, Ross KG, Sherrer ES, et al, (2012) A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 7: e37004 sernova.com.
107. Shang L, Hua H, Foo K, Martinez H, Watanabe K, Zimmer M, Kahler DJ, Freeby M, Chung W, LeDuc C, Goland R, Leibel RL, Egli D, (2014) beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes 63: 923-933
108. Shieh SJ, Chou FC, Yu PN, Lin WC, Chang DM, Roffler SR, Sytwu HK, (2009) Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. J Immunol 183: 2277-2285
109. Shih HP, Kopp JL, Sandhu M, Dubois CL, Seymour PA, Grapin-Botton A, Sander M, (2012) A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 139: 2488-2499
110. Staeva TP, Chatenoud L, Insel R, Atkinson MA, (2013) Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes 62: 9-17
111. Steck AK, Winter WE, (2011) Review on monogenic diabetes. Curr Opin Endocrinol Diabetes Obes 18: 252-258
112. Suarez-Pinzon WL, Marcoux Y, Ghahary A, Rabinovitch A, (2002) Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction. Cell Transplant 11: 519-528
113. Sui L, Geens M, Sermon K, Bouwens L, Mfopou JK, (2013) Role of BMP signaling in pancreatic progenitor differentiation from human embryonic stem cells. Stem Cell Rev 9: 569-577
114. Sun X, Xu J, Lu H, Liu W, Miao Z, Sui X, Liu H, Su L, Du W, He Q, Chen F, Shi Y, Deng H, (2013) Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell 13: 230-236
115. Swann JB, Smyth MJ, (2007) Immune surveillance of tumors. J Clin Invest 117: 1137-1146
116. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, Kang E, Fulati A, Lee HS, Sritanaudomchai H, Masterson K, Larson J, Eaton D, Sadler-Fredd K, Battaglia D, Lee D, Wu D, Jensen J, Patton P, Gokhale S, et al, (2013) Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153: 1228-1238
117. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872
118. Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D, (2012) Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet 44: 406-412, S401
119. Tam PP, Kanai-Azuma M, Kanai Y, (2003) Early endoderm development in vertebrates: lineage differentiation and morphogenetic function. Curr Opin Genet Dev 13: 393-400
120. Teo AK, Windmueller R, Johansson BB, Dirice E, Njolstad PR, Tjora E, Raeder H, Kulkarni RN, (2013) Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young. J Biol Chem 288: 5353-5356
121. Thanabalasingham G, Owen KR, (2011) Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 343: d6044
122. Thisse B, Wright CV, Thisse C, (2000) Activin- and Nodal-related factors control antero-posterior patterning of the zebrafish embryo. Nature 403: 425-428
123. Thompson JA, Perry D, Brusko TM, (2012) Autologous regulatory T cells for the treatment of type 1 diabetes. Curr Diab Rep 12: 623-632
124. Todd JA, (2010) Etiology of type 1 diabetes. Immunity 32: 457-467
125. Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y, Crossland DL, Huls H, Littman N, Zhang Z, Tykodi SS, Kebriaei P, Lee DA, Miller JC, Rebar EJ, Holmes MC, Jaenisch R, Champlin RE, Gregory PD, Cooper LJ, (2013) Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 122: 1341-1349
126. Turner M, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I, (2013) Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 13: 382-384
127. Tyden G, Reinholt FP, Sundkvist G, Bolinder J, (1996) Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335: 860-863
128. Vaxillaire M, Froguel P, (2008) Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 29: 254-264
129. Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, Molano RD, Diamantopoulos S, Standifer N, Geubtner K, Falk BA, Ichii H, Takahashi H, Snowhite I, Chen Z, Mendez A, Chen L, Sageshima J, Ruiz P, Ciancio G, Ricordi C, et al, (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59: 947-957
130. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH, (1992) Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202: 1-8
131. Wandzioch E, Zaret KS, (2009) Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 324: 1707-1710
132. Wang T, Wu H, Li Y, Szulwach KE, Lin L, Li X, Chen IP, Goldlust IS, Chamberlain SJ, Dodd A, Gong H, Ananiev G, Han JW, Yoon YS, Rudd MK, Yu M, Song CX, He C, Chang Q, Warren ST, Jin P, (2013) Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat Cell Biol 15: 700-711
133. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ, (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630
134. Weber LM, Cheung CY, Anseth KS, (2008) Multifunctional pancreatic islet encapsulation barriers achieved via multilayer PEG hydrogels. Cell Transplant 16: 1049-1057
135. Weissbein U, Ben-David U, Benvenisty N, (2014) Virtual karyotyping reveals greater chromosomal stability in neural cells derived by transdifferentiation than those from stem cells. Cell Stem Cell 15: 687-691
136. Whitman M, (2001) Nodal signaling in early vertebrate embryos: themes and variations. Dev Cell 1: 605-617
137. Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, Paull D, Nestor MW, Freeby M, Greenberg E, Goland RS, Leibel RL, Solomon SL, Benvenisty N, Sauer MV, Egli D, (2014) Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature 510: 533-536
138. Yang H, O'Hali W, Kearns H, Wright JR Jr, (1997) Long-term function of fish islet xenografts in mice by alginate encapsulation. Transplantation 64: 28-32
139. Zaldumbide A, Alkemade G, Carlotti F, Nikolic T, Abreu JR, Engelse MA, Skowera A, de Koning EJ, Peakman M, Roep BO, Hoeben RC, Wiertz EJ, (2013) Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo. Mol Ther 21: 1592-1601
140. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA, (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627-632